LACEY STOCKTON: Open Payments
NPI 1710763065 · ROLLA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 17 payments from 9 companies in 2025. Trend: 2023 $27 · 2024 $394 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $87 |
| Amgen Inc. | 3 | $60 |
| Dexcom, Inc. | 2 | $57 |
| SCPHARMACEUTICALS INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: Dexcom G6 Transmitter, Wegovy, EVENITY, FUROSCIX, MOUNJARO, Ozempic, GEMTESA, JARDIANCE.
Industry payments across MO — which companies pay providers there.
